GoodRx co-CEO explains how its new service helps patients access medical care for just $20

Brasil Notícia Notícia

GoodRx co-CEO explains how its new service helps patients access medical care for just $20
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 CNBC
  • ⏱ Reading Time:
  • 38 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 72%

'We wanted to just have an easy solution that anyone could use to get quick care of the most pressing things that affect millions and millions of Americans,' GoodRx co-CEO Doug Hirsch says.

GoodRx's website lists the services it provides. Most are just $20, although those that require a lab may cost more. A visit for acne treatment is $20, whereas tuberculosis testing and referral, for example, is $100.

"We're a market place in prescriptions, and with GoodRx Care, we're a market place for both prices for medical care and we're even offering medical care," Hirsch said. "The only difference was I used GoodRx, which is why I said I can't believe others don't, " Cramer said. "I frankly didn't believe it ... It's like fantasy land.", is able to accomplish savings on prescription drugs. The company claims it has helped Americans save $10 billion on prescriptions.

"One of the amazing things about American health care these days is there are often huge gaps in care," Hirsch said, adding that, in certain areas, it can sometimes take up to 30 days to see a doctor.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

CNBC /  🏆 12. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Health insurance CEO resigns after DUI arrest becomes publicHealth insurance CEO resigns after DUI arrest becomes publicThe CEO of BlueCross BlueShield of North Carolina, whose June arrest for driving under the influence became public last week, resigned Wednesday amid accusations of a coverup.
Consulte Mais informação »

Despite Adam Neumann’s Departure As CEO, We Is Still A Horrible InvestmentDespite Adam Neumann’s Departure As CEO, We Is Still A Horrible InvestmentWeWork needs a scalable business model and a new CEO probably can't deliver one
Consulte Mais informação »

Philip Morris International CEO on ending merger talks with AltriaPhilip Morris International CEO on ending merger talks with AltriaWould Philip Morris and Altria have reached a deal if there wasn’t a crackdown on vaping? Here’s what the CEO of Philip Morris International had to say in his exclusive interview with davidfaber.
Consulte Mais informação »

Philip Morris CEO on Altria and the future of e-cigarettesPhilip Morris CEO on Altria and the future of e-cigarettes“We have to be careful here not to have an overexaggerated reaction.” Philip Morris International’s CEO calls for “moderation” in responding to the vaping epidemic. Watch the full interview here:
Consulte Mais informação »

Peloton CEO John Foley Faces The Skeptics Again: This Time, Buyers In Its $8 Billion IPOPeloton CEO John Foley Faces The Skeptics Again: This Time, Buyers In Its $8 Billion IPOPeloton cofounder John Foley says 400 investors turned down his idea of an Internet-connected fitness bike. Now he has to convince public investors of the same thing. 'We're on the first out of the first inning of where we want to take this business,' he says.
Consulte Mais informação »



Render Time: 2025-04-06 06:30:48